Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Sartorius AG    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/29 09:33:49 am
331 EUR   +0.91%
10/23SARTORIUS VORZUEGE : Berenberg reaffirms its Neutral rating
MD
10/22SARTORIUS VORZUEGE : Gets a Sell rating from DZ Bank
MD
10/21SARTORIUS VORZUEGE : NorldLB sticks Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sartorius : successfully places note loan with a volume of 750 million euros

share with twitter share with LinkedIn share with facebook
09/09/2020 | 10:00am EDT
Sartorius successfully places note loan with a volume of 750 million euros

Göttingen, September 9, 2020

  • Transaction oversubscribed more than three times
  • Volume increased from 300 million euros to 750 million euros

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, successfully placed a note loan with a volume of 750 million euros. The note loan was issued with maturity terms of 3, 5, 7 and 10 years and was significantly oversubscribed. 'We see such great interest as clear proof of our attractiveness for investors,' said Rainer Lehmann, Chief Financial Officer of Sartorius.

In view of high demand, the targeted minimum volume of 300 million euros was significantly exceeded. Most of the funds will be used for early repayment of the bridge loan that Sartorius had taken out at the end of April in connection with the acquisition of selected life science businesses from Danaher.

September 09, 2020
Sartorius successfully places note loan with a volume of 750 million euros
PDF55.8 KB

Disclaimer

Sartorius AG published this content on 09 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 September 2020 12:59:03 UTC


share with twitter share with LinkedIn share with facebook
All news about SARTORIUS AG
10/23SARTORIUS VORZUEGE : Berenberg reaffirms its Neutral rating
MD
10/22SARTORIUS VORZUEGE : Gets a Sell rating from DZ Bank
MD
10/21SARTORIUS VORZUEGE : NorldLB sticks Neutral
MD
10/21SARTORIUS VORZUEGE : Deutsche Bank sticks Neutral
MD
10/21SARTORIUS VORZUEGE : Warburg Research reaffirms its Neutral rating
MD
10/20SARTORIUS : Conference Call 9M|2020 Presentation
PU
10/20SARTORIUS VORZUEGE : Warburg Research reiterates its Neutral rating
MD
10/20SARTORIUS VORZUEGE : Berenberg sticks Neutral
MD
10/20SARTORIUS : Earnings Release 9M|2020
PU
10/20SARTORIUS VORZUEGE : JP Morgan remains its Buy rating
MD
More news
Financials
Sales 2020 2 301 M 2 692 M 2 692 M
Net income 2020 249 M 291 M 291 M
Net Debt 2020 1 756 M 2 054 M 2 054 M
P/E ratio 2020 114x
Yield 2020 0,25%
Capitalization 24 243 M 28 501 M 28 359 M
EV / Sales 2020 11,3x
EV / Sales 2021 9,57x
Nbr of Employees 9 729
Free-Float 46,8%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 229,92 €
Last Close Price 328,00 €
Spread / Highest target -2,44%
Spread / Average Target -29,9%
Spread / Lowest Target -79,0%
EPS Revisions
Managers
NameTitle
Joachim Kreuzburg Chief Executive Officer
Lothar Kappich Chairman-Supervisory Board
Volker Niebel Head-Production, Procurement & Business Operations
Rainer Lehmann Chief Financial Officer
Oscar-Werner Reif Head-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS AG87.43%28 501
REVENIO GROUP OYJ29.14%1 056
CELLAVISION AB (PUBL)-13.68%744
ALPHATEC HOLDINGS, INC.19.24%657
VAREX IMAGING CORPORATION-56.66%505
CO-DIAGNOSTICS, INC.1,418.66%384